The Urology Department of Edouard Herriot Hospital (“HEH“) in Lyon, France, has been a pioneer in the treatment of local recurrent prostate cancer after failed radiotherapy. A recent article by Dr. Albert Gelet of HEH and Dr. Guy Vallancien of Institut Mutualiste Monsouris (“IMM”) in Paris, published in Urology , reported that 71 patients, who initially showed indications of recurrent prostate cancer after radiotherapy, were treated using HIFU with Ablatherm. The conclusion of this article showed very satisfactory results with 80% negative biopsies, with up to seven years follow-up and low side effects in this population.